Symbol="GNLX"
AssetType="Common Stock"
Name="Genelux Corporation Common Stock"
Description="Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The company is headquartered in Westlake Village, California."
CIK="1231457"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, UNITED STATES"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="778997000"
EBITDA="-5460000"
PERatio="None"
PEGRatio="None"
BookValue="0.112"
DividendPerShare="0"
DividendYield="0"
EPS="-0.45"
RevenuePerShareTTM="0.958"
ProfitMargin="-1.047"
OperatingMarginTTM="-0.535"
ReturnOnAssetsTTM="-0.303"
ReturnOnEquityTTM="0"
RevenueTTM="11238000"
GrossProfitTTM="11068000"
DilutedEPSTTM="-0.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="31.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="40.98"
num_52WeekLow="5.35"
num_50DayMovingAverage="28.86"
num_200DayMovingAverage="23.82"
SharesOutstanding="25983900"
DividendDate="None"
ExDividendDate="None"
symbol="GNLX"
open="28.27"
high="29.74"
low="26.34"
price="26.80"
volume="155172.00"
latest_trading_day="2023-08-10"
previous_close="29.98"
change="-3.18"
change_percent="-10.6071%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="20"
trend_strength="Strong Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="51996"
Change_recent_avg="-0.22"
Delta_recent_avg="2.8"
Variance_recent_avg="1.4"
Change_ratio_recent_avg="-0.97"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="20"
image_negative_thumbnail_id_1="118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_negative_thumbnail_id_2="493"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="687"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_positive_thumbnail_id_2="1004"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
